As of February 17, 2025, 1,028 unique patient prescriptions for Attruby have been written by 516 unique prescribers since FDA approval - Attruby (acoramidis), the first and only near-complete TTR ...

"Excellent finish to the year with strong growth and high profitability" Fourth quarter and full year summary October - December Total revenues grew 48% (44% at CER1) to SEK 553 (375) million Sales ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...

Despite the acceleration of knowledge and data accumulation in neuroscience over the last years, the highly prevalent neurodegenerative disease of AD remains a growing problem. Alzheimer's Disease (AD ...

Then he responded: "Okay, the gene is autosomal dominant, which means each time you conceive ... her height measured above the 95th percentile on the standardized growth chart. Today, as a ...

By contrast, the coveted Best New Artist prize is pretty much a two-way split between Chappell Roan and Sabrina Carpenter, both of whom established a dominant chart presence in 2024 after years on ...

By contrast, the coveted best new artist prize is pretty much a two-way split between Chappell Roan and Sabrina Carpenter, both of whom established a dominant chart presence in 2024 after years on ...

(NASDAQ:RGLS), a biopharmaceutical company currently trading at $1.17 per share, today announced significant clinical and regulatory advancements in its Autosomal Dominant Polycystic Kidney ...

autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. The shakeup in the AI space has spread waves across the stock market. Here’s what investors need to know.

APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Multi-target stool DNA test adherence among average-risk 45- to 49-year-old patients from 2017-2023. Refining colorectal cancer screening strategies using polygenic risk scores and classical risk ...

Eric Clapton’s fifth solo album Slowhand debuts on Billboard's Top Blues Albums chart at No. 2, ... [+] nearly netting the guitarist another No. 1. British guitarist Eric Clapton performing on ...